Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors
1 clinical trials · Condition
◉ Watch Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors
| Record | Firm | Date |
|---|---|---|
| Haploid Allogeneic Transplant Using the CliniMACS System (NCT00185679) | Ginna Laport | 2001-11-01 |
Track Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors automatically
Every clearance here is in the API, with alerts when new ones post.